ARB-treated women have higher risk of new-onset diabetes

04/22/2012 | Diabetes.co.uk (U.K.)

Hypertensive women who were prescribed angotensin receptor blockers were 93% more likely to develop new-onset diabetes compared with those who received angiotensin-converting-enzyme inhibitors, a study in the Journal of Clinical Hypertension revealed. More study is needed but the findings may aid in decision-making among clinicians, the lead researcher said.

View Full Article in:

Diabetes.co.uk (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC